Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Neuronal Signaling|July 17, 2023
Inflammation in the pathogenesis of depression: a disorder of neuroimmune originMyles Corrigan, Aoife M O'Rourke, Barry Moran, et al.Pharmacology Research & Perspectives|April 13, 2016
Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanismEimear O'Neill, Billy Kwok, Jennifer S Day, et al.Brain, Behavior, and Immunity|May 8, 2019
Persistent central inflammation and region specific cellular activation accompany depression- and anxiety-like behaviours during the resolution phase of experimental colitisElaine Dempsey, Áine Abautret-Daly, Neil G Docherty, et al.Acta Neuropsychiatrica|March 9, 2017
Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel diseaseÁine Abautret-Daly, Elaine Dempsey, Adolfo Parra-Blanco, et al.Brain, Behavior, and Immunity|January 18, 2018
Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's diseaseJustin D Yssel, Eoin O'Neill, Yvonne M Nolan, et al.Acta Neuropsychiatrica|October 17, 2024
Gene expression of kynurenine pathway enzymes in depression and following electroconvulsive therapyKaren M Ryan, Myles Corrigan, Therese M Murphy, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|January 3, 2021
Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical NeuronsKate O'Reilly, Katherine O'Farrell, Oivind Midttun, et al.Pilot and Feasibility Studies|December 15, 2016
Ketamine for depression relapse prevention following electroconvulsive therapy: protocol for a randomised pilot trial (the KEEP-WELL trial)Martha Finnegan, Karen Ryan, Enda Shanahan, et al.Brain, Behavior, and Immunity|July 6, 2010
The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicityLorna C Gleeson, Katie J Ryan, Eadaoin W Griffin, et al.The International Journal of Neuropsychopharmacology|December 3, 2008
Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegenerationJoan B O'Sullivan, Karen M Ryan, Niamh M Curtin, et al.Pageof 9